Cabaletta Bio (NASDAQ:CABA – Free Report) had its target price raised by Wells Fargo & Company from $34.00 to $35.00 in a report issued on Friday, Benzinga reports. The brokerage currently has an overweight rating on the stock. A number of other research analysts also recently commented on the stock. Morgan Stanley reduced their price […]
Cantor Fitzgerald restated their overweight rating on shares of Cabaletta Bio (NASDAQ:CABA – Free Report) in a report published on Friday, Benzinga reports. They currently have a $50.00 price target on the stock. Several other brokerages also recently weighed in on CABA. William Blair restated an outperform rating and set a $38.00 price objective on […]
Cabaletta Bio (NASDAQ:CABA – Get Free Report) and Aptose Biosciences (NASDAQ:APTO – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation. Volatility and Risk Cabaletta Bio has a […]
Cabaletta Bio (NASDAQ:CABA – Get Free Report) and Aptose Biosciences (NASDAQ:APTO – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, risk, earnings, valuation and institutional ownership. Analyst Recommendations This is a breakdown of […]
Cabaletta Bio (NASDAQ:CABA) & Aptose Biosciences (NASDAQ:APTO) Critical Survey theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.